does glp 1 help with cholesterol GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Potential of Glucagon-Like Peptide 1
Description
Future work will explore further optimization of drug release kinetics, long-term safety across larger animal models, and eventual clinical translation of this technology for type 2 diabetes and metabolic disorders
Monitor fasting glucose, HbA1c, lipid panel, B12 levels, thyroid function, liver enzymes, and kidney function
Duval SJ, Tweedie RL
Bhardwaj, P., Iyengar, N
Five studies were duplicates
Instead, its employee health plan is expected to be $17 million over budget as spending on GLP-1 weight-loss drugs increases and high-cost medical claims rise
